Cancers, Vol. 16, Pages 1266: The Use of CA-125 KELIM to Identify Which Patients Can Achieve Complete Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Serous Advanced Ovarian Cancer

Conclusions: KELIM seems to safely triage patients after neoadjuvant chemotherapy and decide who will benefit from IDS.

Source: Cancers - March 24, 2024 Category: Cancer & Oncology Authors: Dimitrios Zouzoulas Dimitrios Tsolakidis Panagiotis Tzitzis Iliana Sofianou Kimon Chatzistamatiou Vasilis Theodoulidis Maria Topalidou Eleni Timotheadou Grigoris Grimbizis Tags: Article Source Type: research